In vitro pharmacological evaluation of the novel NOP receptor partial agonist sunobinop
Biochemical Pharmacology · 2025
DOI: 10.1016/j.bcp.2025.116972 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Pharmacology, 2025. Verfasst von Riccardo Camilotto und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical and Pharmacological Sciences, Section of Pharmacology, University of Padova, Padova, Italy. Hauptthemen laut MEDLINE: Receptors, Opioid. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministero dell'Istruzione dell'Universita e della Ricerca, Università degli Studi di Ferrara, Università degli Studi di Padova.
Abstract (Originalsprache)
Sleep-related disorders affect a significant portion of the global population. The nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor has become a promising candidate for the development of innovative drugs to treat sleep disorders. In this study, we conducted an in-depth pharmacological characterization of sunobinop, a selective NOP receptor partial agonist already under clinical evaluation for treating multiple conditions including insomnia, using a wide range of in vitro and ex vivo methodologies. Sunobinop exhibited partial agonist activity in calcium mobilization, NOP - G protein interaction, label-free bioimpedance, and cAMP inhibition assays. Notably, it demonstrated competitive antagonism in the NOP - β-Arrestin 2 recruitment and ex vivo electrically stimulated mouse Vas Deferens, assays characterized by low amplification. The findings reported here confirm and extend the characterization of sunobinop as a tool for studying NOP receptor pharmacology providing new insights into its mode of action, relevant to its clinical evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical and Pharmacological Sciences, Section of Pharmacology, University of Padova, Padova, Italy.
- Department of Pharmaceutical and Pharmacological Sciences, Section of Pharmacology, University of Padova, Padova, Italy. Electronic address: davide.malfacini@unipd.it.
- Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy.
- Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy.
- Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy; LTTA Laboratory for Advanced Therapies, Technopole of Ferrara 44121 Ferrara, Italy.
- Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy; LTTA Laboratory for Advanced Therapies, Technopole of Ferrara 44121 Ferrara, Italy.
Förderung
- Ministero dell'Istruzione dell'Universita e della Ricerca
- Università degli Studi di Ferrara
- Università degli Studi di Padova
- Kaiser Permanente Division of Research
- University of Ferrara Department of Chemical and Pharmaceutical Sciences
- Ministero dell’Istruzione, dell’Università e della Ricerca
Zitieren
APA
Camilotto, R., Malfacini, D., Pola, P., Morrone, E., Frezza, A., Ramalingam, R., Sturaro, C., Pacifico, S., Ruzza, C., Guerrini, R., Whiteside, G., & Calo', G. (2025). In vitro pharmacological evaluation of the novel NOP receptor partial agonist sunobinop. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2025.116972
Vancouver
Camilotto R, Malfacini D, Pola P, Morrone E, Frezza A, Ramalingam R, et al. In vitro pharmacological evaluation of the novel NOP receptor partial agonist sunobinop. Biochemical Pharmacology. 2025. doi:10.1016/j.bcp.2025.116972
BibTeX
@article{Camilotto2025,
author = {Camilotto, Riccardo and Malfacini, Davide and Pola, Pietro and Morrone, Erika and Frezza, Alessia and Ramalingam, Rahul and Sturaro, Chiara and Pacifico, Salvatore and Ruzza, Chiara and Guerrini, Remo and Whiteside, Garth and Calo', Girolamo},
title = {In vitro pharmacological evaluation of the novel NOP receptor partial agonist sunobinop},
journal = {Biochemical Pharmacology},
year = {2025},
doi = {10.1016/j.bcp.2025.116972}
}
EUVIMED